Date of release: Monday, August 24, 2015

Jeremy Everett BookThe search for new drugs which can fight all human diseases is the subject of a major new book co-edited by a University of Greenwich scientist.

Jeremy Everett, Professor of Pharmaceutical Technologies, is an internationally recognised expert on drug discovery and how individuals respond to drug treatment.

Based at the Medway Campus, within the university's Faculty of Engineering & Science, he has held a variety of technology leadership positions for Pfizer, SmithKline Beecham and Beecham Research Laboratories.

He also contributes two chapters to the book, NMR in Pharmaceutical Sciences.

It describes how nuclear magnetic resonance – NMR – is used at all stages of drug discovery, development and manufacture.

In a typical NMR experiment, samples of a drug are placed in an immensely strong magnetic field and then pulsed with radiofrequency energy. The process gives scientists details about the structure and purity of drug molecules, and the way in which they behave in the human body, which is critically important when they are discovering new drugs to battle disease.

Published by Wiley, the title has an international release, including the UK, USA, Asia, Australasia and the Middle East.

Professor Everett says: "Our new book will, I hope, be essential reading for scientists in the pharmaceutical sector.

"It will also be a valuable guide for the wider array of academic and industrial scientists, who need to better understand the way in which NMR informs complex processes and decision-making in the pharmaceutical industry. This ranges from discovering new drugs to obtaining regulatory approval and patent protection."

The title's 31 chapters cover other topics such as personalised medicine and the process of finding new drugs from plants and other natural sources. It also explains how the related technology of MRI (magnetic resonance imaging) is used to study the effectiveness and safety of new drugs.

Personalised or precision medicines – advanced methods of targeting the right treatment to the right patient group – are among Professor Everett's other specialisms.

He has strong research interests in profiling the substances found in human biofluids such as urine and plasma, an area of science known as metabonomics.

His fellow co-editors are John C. Lindon and Ian D. Wilson (both Imperial College London) and Robin K. Harris, University of Durham.

For more on studying with the Faculty of Engineering & Science:

Story by Public Relations